Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T68345 |
GTS511
|
||
GTS511 is a EAAT2 Activator. Pharmacokinetic profiles (PK) of GTS511 show a >6 h half-life and higher bioavailability in plasma and the brain under all three routes of administration in rats. GTS511 can be further developed to treat neurological disorders caused by excitotoxicity |